The results showed that ATP1A1 and ATP1A2 were highly expressed in VSMCs of the normal aorta (Figure 5F, G), and the protein level of ATP1A2 was dramatically reduced in the aorta of patients with AAA (Figure 5G‐I), which confirmed the above analysis results. This evidence concerns the gene ATP1A1 and triple-A syndrome.